药代-话题@MedSci

#药代#

158篇内容 | 2838人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1666659, encodeId=448716666594b, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=备案制下的医药代表的未来在哪里？, objectType=article, longId=106841, objectId=4cd210684107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cd210684107, replyNumber=0, likeNumber=28, createdTime=2017-11-15, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cd210684107, moduleTitle=备案制下的医药代表的未来在哪里？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cd210684107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666686, encodeId=59c2166668602, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Chest：四种静脉维生素C给药方案在危重症患者的药代动力学分析, objectType=article, longId=131724, objectId=e2dc131e24ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2dc131e24ed, replyNumber=0, likeNumber=59, createdTime=2018-06-25, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2dc131e24ed, moduleTitle=Chest：四种静脉维生素C给药方案在危重症患者的药代动力学分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2dc131e24ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666666, encodeId=f61a1666666e8, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=「全球很大医院」发通知：药代开始备案, objectType=article, longId=111405, objectId=f22611140548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f22611140548, replyNumber=0, likeNumber=55, createdTime=2018-06-13, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f22611140548, moduleTitle=「全球很大医院」发通知：药代开始备案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f22611140548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666679, encodeId=7dbf16666e938, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=浙江曝新闻，药代拜访有剧变, objectType=article, longId=125852, objectId=ef1612585222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef1612585222, replyNumber=0, likeNumber=67, createdTime=2018-06-19, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef1612585222, moduleTitle=浙江曝新闻，药代拜访有剧变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef1612585222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666662, encodeId=cfbf1666662f2, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=收药代两支笔，涉事医生被处理了, objectType=article, longId=108645, objectId=9085108645ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9085108645ad, replyNumber=0, likeNumber=44, createdTime=2017-08-24, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9085108645ad, moduleTitle=收药代两支笔，涉事医生被处理了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9085108645ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666660, encodeId=440016666601c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=上海市：自费药也被全面监控药代将遭严查, objectType=article, longId=107060, objectId=cdc810e0602d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdc810e0602d, replyNumber=0, likeNumber=83, createdTime=2018-06-30, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdc810e0602d, moduleTitle=上海市：自费药也被全面监控药代将遭严查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdc810e0602d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666671, encodeId=325416666e145, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=药代所有个人信息要被公开？, objectType=article, longId=116060, objectId=6f2e116060a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f2e116060a1, replyNumber=0, likeNumber=40, createdTime=2018-05-21, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f2e116060a1, moduleTitle=药代所有个人信息要被公开？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f2e116060a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666665, encodeId=4f8116666652c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=重庆各医院装摄像头卫计委直接监控药代, objectType=article, longId=111311, objectId=0bee1113113e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bee1113113e, replyNumber=0, likeNumber=39, createdTime=2018-04-14, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bee1113113e, moduleTitle=重庆各医院装摄像头卫计委直接监控药代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bee1113113e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666668, encodeId=49ff1666668d6, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=食药监总局：医药代表不得售药, objectType=article, longId=115614, objectId=0eec11561405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0eec11561405, replyNumber=0, likeNumber=45, createdTime=2018-02-25, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0eec11561405, moduleTitle=食药监总局：医药代表不得售药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eec11561405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666690, encodeId=5fb4166669056, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医药代表，你被监控了, objectType=article, longId=138101, objectId=90c113810162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90c113810162, replyNumber=0, likeNumber=60, createdTime=2018-12-01, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90c113810162, moduleTitle=医药代表，你被监控了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90c113810162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666677, encodeId=11c416666e733, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医药代表从业新规征求意见：医药代表不得承担药品销售任务, objectType=article, longId=125018, objectId=1a53125018de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a53125018de, replyNumber=0, likeNumber=55, createdTime=2018-02-06, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a53125018de, moduleTitle=医药代表从业新规征求意见：医药代表不得承担药品销售任务, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a53125018de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666675, encodeId=eec716666e547, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=国家版药代备案制征求意见医药代表行为法制化, objectType=article, longId=124380, objectId=3ac412438095, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ac412438095, replyNumber=0, likeNumber=66, createdTime=2018-11-11, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ac412438095, moduleTitle=国家版药代备案制征求意见医药代表行为法制化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ac412438095)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666684, encodeId=d0611666684e5, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=2017，药代离职率创新高, objectType=article, longId=129600, objectId=63751296003f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63751296003f, replyNumber=0, likeNumber=68, createdTime=2018-08-23, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63751296003f, moduleTitle=2017，药代离职率创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63751296003f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666681, encodeId=0331166668137, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=PLOS Medicine: Fc修饰的HIV-1人单克隆抗体-VRC01LS的安全性和药代动力学研究, objectType=article, longId=128453, objectId=eaad128453cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaad128453cc, replyNumber=0, likeNumber=0, createdTime=2018-04-19, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaad128453cc, moduleTitle=PLOS Medicine: Fc修饰的HIV-1人单克隆抗体-VRC01LS的安全性和药代动力学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaad128453cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666672, encodeId=904616666e233, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=只有生产企业才能为医药代表备案，CSO和经销商路在何方？, objectType=article, longId=116338, objectId=769b11633812, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=769b11633812, replyNumber=0, likeNumber=71, createdTime=2018-01-22, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=769b11633812, moduleTitle=只有生产企业才能为医药代表备案，CSO和经销商路在何方？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=769b11633812)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666657, encodeId=815e166665e75, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=Invest Ophthalmol Vis Sci：PET可以作为非侵入性的手段来研究玻璃体内注射的药代动力学特征！, objectType=article, longId=100608, objectId=0a261006081d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a261006081d, replyNumber=0, likeNumber=51, createdTime=2018-02-16, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a261006081d, moduleTitle=Invest Ophthalmol Vis Sci：PET可以作为非侵入性的手段来研究玻璃体内注射的药代动力学特征！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a261006081d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666650, encodeId=417916666508b, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=九家市属医院实现汤药代煎代送让吃药更方便, objectType=article, longId=95628, objectId=df2995628d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2995628d8, replyNumber=0, likeNumber=73, createdTime=2017-11-04, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2995628d8, moduleTitle=九家市属医院实现汤药代煎代送让吃药更方便, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2995628d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666664, encodeId=7547166666442, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=上海发布新规：药代全部备案, objectType=article, longId=110965, objectId=ea7a1109655f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea7a1109655f, replyNumber=0, likeNumber=0, createdTime=2018-03-28, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea7a1109655f, moduleTitle=上海发布新规：药代全部备案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea7a1109655f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666663, encodeId=951216666637b, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=河南药代全国最多！这类药代必遭淘汰！, objectType=article, longId=108734, objectId=16c8108e3404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16c8108e3404, replyNumber=0, likeNumber=72, createdTime=2018-07-29, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16c8108e3404, moduleTitle=河南药代全国最多！这类药代必遭淘汰！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16c8108e3404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666651, encodeId=c3de166665181, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=PLos One：庆大霉素在感染性心内膜炎治疗中的药代动力学模型, objectType=article, longId=98309, objectId=51469830949, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51469830949, replyNumber=0, likeNumber=56, createdTime=2018-01-05, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51469830949, moduleTitle=PLos One：庆大霉素在感染性心内膜炎治疗中的药代动力学模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51469830949)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药代

2020-05-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

备案制下的医药代表的未来在哪里？

2017-11-15

fengyqf (审核中...)

前往app查看评论内容

#药代#

Chest：四种静脉维生素C给药方案在危重症患者的药代动力学分析

2018-06-25

fengyqf (审核中...)

前往app查看评论内容

#药代#

「全球很大医院」发通知：药代开始备案

2018-06-13

fengyqf (审核中...)

前往app查看评论内容

#药代#

浙江曝新闻，药代拜访有剧变

2018-06-19

fengyqf (审核中...)

前往app查看评论内容

#药代#

收药代两支笔，涉事医生被处理了

2017-08-24

fengyqf (审核中...)

前往app查看评论内容

#药代#

上海市：自费药也被全面监控药代将遭严查

2018-06-30

fengyqf (审核中...)

前往app查看评论内容

#药代#

药代所有个人信息要被公开？

2018-05-21

fengyqf (审核中...)

前往app查看评论内容

#药代#

重庆各医院装摄像头卫计委直接监控药代

2018-04-14

fengyqf (审核中...)

前往app查看评论内容

#药代#

食药监总局：医药代表不得售药

2018-02-25

fengyqf (审核中...)

前往app查看评论内容

#药代#

医药代表，你被监控了

2018-12-01

fengyqf (审核中...)

前往app查看评论内容

#药代#

医药代表从业新规征求意见：医药代表不得承担药品销售任务

2018-02-06

fengyqf (审核中...)

前往app查看评论内容

#药代#

国家版药代备案制征求意见医药代表行为法制化

2018-11-11

fengyqf (审核中...)

前往app查看评论内容

#药代#

2017，药代离职率创新高

2018-08-23

fengyqf (审核中...)

前往app查看评论内容

#药代#

PLOS Medicine: Fc修饰的HIV-1人单克隆抗体-VRC01LS的安全性和药代动力学研究

2018-04-19

fengyqf (审核中...)

前往app查看评论内容

#药代#

只有生产企业才能为医药代表备案，CSO和经销商路在何方？

2018-01-22

fengyqf (审核中...)

前往app查看评论内容

#药代#

Invest Ophthalmol Vis Sci：PET可以作为非侵入性的手段来研究玻璃体内注射的药代动力学特征！

2018-02-16

fengyqf (审核中...)

前往app查看评论内容

#药代#

九家市属医院实现汤药代煎代送让吃药更方便

2017-11-04

fengyqf (审核中...)

前往app查看评论内容

#药代#

上海发布新规：药代全部备案

2018-03-28

fengyqf (审核中...)

前往app查看评论内容

#药代#

河南药代全国最多！这类药代必遭淘汰！

2018-07-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

PLos One：庆大霉素在感染性心内膜炎治疗中的药代动力学模型

2018-01-05

科室
- - 订阅+
  - 更多科室
工具
服务